The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis

Ozelle will unveil O-Cyte 1, our newest automated hematology analyzer, at ADLM 2026 in Anaheim, California. Making its global debut at one of the leading international events for diagnostics and laboratory medicine, O-Cyte 1 marks Ozelle’s latest milestone in advancing the 4th Generation of Hematology Analysis through AI × CBM (Complete Blood Morphology).

AI × CBM: Bringing Morphology Intelligence into Routine Hematology Workflows

For decades, cellular morphology has remained one of the most valuable sources of hematology insight. Yet bringing morphology into routine hematology workflows without slowing productivity has remained a challenge. Manual microscopy depends heavily on specialist expertise, while image-based approaches have expanded what laboratories can see, but translating that visibility into high-throughput routine workflows has remained difficult.

O-Cyte 1 is designed to address this gap by bringing morphology intelligence, scalable throughput, and operational simplicity into one compact system. Built on Ozelle’s AI × CBM technology, the analyzer transforms cell images into structured morphology insight, supporting a workflow that moves beyond numerical parameters toward image-based evidence and consistent interpretation.

Scalable Hematology Throughput for Diverse Clinical Settings

Designed for productive clinical workflows, O-Cyte 1 supports up to 60 tests per hour as a standalone unit and up to 360 tests per hour through cascaded expansion. This architecture is intended to support a broad range of hematology scenarios, including independent laboratories, hospitals, health screening centers, emergency and outpatient settings, and regional laboratory networks.

“O-Cyte 1 reflects our vision of making advanced morphology intelligence more practical, scalable, and accessible for everyday hematology workflows,” said Raymond,head of Ozelle North America division. “At ADLM 2026, we look forward to showing global partners how AI-powered morphology can move into more productive hematology workflows.”

For daily operation, O-Cyte 1 is built around a compact footprint, modular architecture, minimal-maintenance workflow, and service-ready design. These features are intended to help healthcare providers and laboratory operators improve efficiency while reducing operational complexity.

At ADLM 2026, Ozelle will present O-Cyte 1 alongside our expanding clinical hematology portfolio. As demand grows for efficient, scalable, and accessible hematology solutions across global markets, including North America, Europe, the Middle East, Southeast Asia, India, and beyond, Ozelle aims to support diverse clinical settings with AI-powered diagnostic systems designed for everyday hematology workflows.

Visitors and partners are invited to experience O-Cyte 1 at Booth 2517 during ADLM 2026, July 28–30, at the Anaheim Convention Center. Partners unable to attend in person are also welcome to request a product briefing and explore regional collaboration opportunities. To receive O-Cyte 1 launch updates or schedule a meeting with the Ozelle team, please visit: https://forms.gle/HWkFmcpzPW2WTM7x9